CRVO
CervoMed Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
John J. Alam
IPO Date
2008-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
CervoMed Inc.
CEO
John J. Alam
IPO Date
2008-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 75,000 |
| $4.80 |
| 13 Feb 2026 | ELDER WILLIAM ROBERT | CFO, GC & Secretary | A-Award | Acquired | 30,000 | $4.80 |
| 13 Feb 2026 | De Rosch Mark | EVP, RA and GA and PgM | A-Award | Acquired | 30,000 | $4.80 |
| 13 Feb 2026 | Blackburn Kelly | EVP, Clinical Development | A-Award | Acquired | 30,000 | $4.80 |
| 13 Feb 2026 | ALAM JOHN J | director, 10 percent owner, officer: CEO & President | A-Award | Acquired | 75,000 | $4.80 |
| 5 Dec 2025 | Quigley David | director | A-Award | Acquired | 16,200 | $7.02 |
| 5 Dec 2025 | Quigley David | director: | Disposed | 0 | $0.00 |
| 19 Nov 2025 | Winton Matthew | Chief Commercial and Business | P-Purchase | Acquired | 3,500 | $8.43 |
| 19 Nov 2025 | Winton Matthew | Chief Commercial and Business | P-Purchase | Acquired | 1,500 | $7.95 |